DE Domestic/Foreign Bulletin No. 146

Ovarian Cancer Screening and Monitoring Tests

Year: 2024Length: 303 wordsOfficial source
NOTE: This Bulletin is intended solely for informational purposes. It is not intended to set forth legal rights, duties, or privileges, nor is it intended to provide legal advice. Readers should consult applicable statutes and rules and contact the Delaware Department of Insurance if additional information is needed. ♦INSURANCE.DELAWARE.GOV♦ 1351 W. NORTH ST., SUITE 101, DOVER, DELAWARE 19904 (302) 674-7300 DOVER♦ (302) 259-7554 GEORGETOWN♦ (302) 577-5280 WILMINGTON TRINIDAD NAVARRO COMMISSIONER STATE OF DELAWARE DEPARTMENT OF INSURANCE DOMESTIC AND FOREIGN INSURERS BULLETIN NO. 146 TO: ALL CARRIERS OFFERING HEALTH INSURANCE IN DELAWARE RE: OVARIAN CANCER SCREENING AND MONITORING TESTS DATED: April 24, 2024 This Bulletin notifies all health insurance carriers in Delaware that the Governor signed House Bill No. 15, with House Amendment No. 1, of the 152nd General Assembly (“the Act”) on March 21, 2024. The Act amends 18 Del. C. § 3338 and 18 Del. C. § 3555 to include coverage for annual screening tests for ovarian cancer and further expands the scope of monitoring tests available to women following treatment for ovarian cancer. The Act covers all group, blanket, and individual health insurance policies (except accident-only, specified disease, hospital indemnity, Medicare supplement, long-term care, disability income, or other limited benefit health insurance policies). After December 31, 2024, all policies, contracts, or certificates issued, renewed, modified, altered, amended, or reissued must incorporate coverage as provided for in the Act on terms at least as favorable as those for mammogram screenings. Accordingly, the Department expects all filings for Plan Year 2025 to include such coverage and requests that carriers inform consumers of the availability of this coverage. Questions about this Bulletin should be emailed to compliance@delaware.gov. This Bulletin shall be effective immediately and shall remain in effect unless withdrawn or superseded by subsequent law, regulation or bulletin. ______________________________________ Trinidad Navarro Delaware Insurance Commissioner
DE Domestic/Foreign Bulletin No. 146: Ovarian Cancer Screening and Monitoring Tests | Justis AI